<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="115">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05159648</url>
  </required_header>
  <id_info>
    <org_study_id>19-008071</org_study_id>
    <nct_id>NCT05159648</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate ICU Simulation Experience in the Cardiothoracic Surgical Population to Reduce Post-operative Delirium</brief_title>
  <official_title>Pre-operative, Multi-sensory ICU Simulation Experience to Reduce Post-operative Delirium in the Cardiothoracic Surgical Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of a pre-ICU admission virtual reality&#xD;
      ICU simulation on post-operative delirium in the elective cardiothoracic surgical population&#xD;
      while in the intensive care unit.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2, 2021</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CAM-ICU</measure>
    <time_frame>Once, during ICU admission within 24 hours of ICU admission.</time_frame>
    <description>&quot;Confusion Assessment Method for the ICU&quot; - Metric of delirium in the intensive care unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective experiential outcome after ICU simulation</measure>
    <time_frame>Once, immediately following the virtual reality ICU simulation session.</time_frame>
    <description>Survey questions to understand patient's subjective experience during the virtual reality ICU simulation session.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective experiential outcome after ICU admission</measure>
    <time_frame>Once, up to 3 days after transfer out of the Intensive Care Unit.</time_frame>
    <description>Survey questions to understand patient's subjective experience in the intensive care unit.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU admission</measure>
    <time_frame>During ICU admission; average 2 days</time_frame>
    <description>Number of hours in the intensive care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of intravenous sedation in the ICU</measure>
    <time_frame>During ICU admission; average 2 days</time_frame>
    <description>Number of hours of intravenous sedation in the ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation in the ICU</measure>
    <time_frame>During ICU admission; average 2 days</time_frame>
    <description>Number of hours of mechanical ventilation in the ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of anti-psychotic medications</measure>
    <time_frame>Throughout ICU admission; average of 5 days</time_frame>
    <description>Number of administrations of anti-psychotic medications in the ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiopulmonary Bypass</measure>
    <time_frame>During OR case; average 12 hours</time_frame>
    <description>Number of hours of use of cardiopulmonary bypass in the operating room</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Post-Operative Delirium</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with normal neurologic function scheduled for elective cardiothoracic surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Baseline normal neurological function pre-operatively.&#xD;
&#xD;
          -  Planned use of mechanical ventilator with endotracheal tube post-operatively after&#xD;
             planned cardiothoracic surgical procedure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic dementia, Alzheimer's disease, or other chronic neurological disease (i.e.,&#xD;
             Bi-Polar).&#xD;
&#xD;
          -  Chronic use of neurological altering medications such as benzodiazepines,&#xD;
             psychotropic, anti-depressants, anxiolytics.&#xD;
&#xD;
          -  Patient undergoing emergent surgery.&#xD;
&#xD;
          -  Use of post-operative cardiopulmonary support devices such as ECMO (extracorporeal&#xD;
             membrane oxygenation), intra-aortic balloon pump, total artificial heart, or other&#xD;
             similar device.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Anderson, APRN, CNP, DNP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Anderson, APRN, DNP, CNP</last_name>
      <phone>507-284-4341</phone>
      <email>anderson.robert2@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>October 13, 2021</study_first_submitted>
  <study_first_submitted_qc>December 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2021</study_first_posted>
  <last_update_submitted>December 10, 2021</last_update_submitted>
  <last_update_submitted_qc>December 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Robert (Bobby) J. Anderson</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

